Vascular Solutions, Inc.  

(Public, NASDAQ:VASC)   Watch this stock  
Find more results for VASC
23.08
+0.16 (0.70%)
Real-time:   11:46AM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range 22.93 - 23.38
52 week 13.92 - 28.21
Open 23.14
Vol / Avg. 42,756.00/60,396.00
Mkt cap 395.26M
P/E 33.65
Div/yield     -
EPS 0.69
Shares 17.13M
Beta 0.13
Inst. own 55%
Jul 21, 2014
Q2 2014 Vascular Solutions, Inc. Earnings Release (Estimated) Add to calendar
May 13, 2014
Vascular Solutions, Inc. at Bank of America Merrill Lynch Health Care Conference Add to calendar
May 7, 2014
Vascular Solutions, Inc. at Deutsche Bank Healthcare Conference Add to calendar
Apr 30, 2014
Vascular Solutions, Inc. Annual Shareholder Meeting - 2:30PM EDT - Add to calendar
Apr 22, 2014
Q1 2014 Vascular Solutions, Inc. Earnings Conference Call - Webcast
Apr 22, 2014
Q1 2014 Vascular Solutions, Inc. Earnings Release
Mar 18, 2014
Vascular Solutions, Inc. at Lazard MedTech, Diagnostics & Healthcare IT Snowbird Conference
Feb 4, 2014
Q4 2013 Vascular Solutions, Inc. Earnings Conference Call - Webcast
Feb 4, 2014
Q4 2013 Vascular Solutions, Inc. Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin 9.36% 10.08%
Operating margin 14.62% 14.57%
EBITD margin - 19.78%
Return on average assets 10.13% 11.36%
Return on average equity 11.46% 12.86%
Employees 406 -
CDP Score - -

Address

6464 SYCAMORE COURT NORTH
MINNEAPOLIS, MN 55369
United States - Map
+1-763-6564300 (Phone)
+1-877-6564251 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Vascular Solutions, Inc. (Vascular) is a medical device company focused on providing clinically advanced solutions to interventional cardiologists and interventional radiologists. Vascular offers product and service in three categories: catheter products, hemostat products and vein products and services. Catheter products consist of catheters used in minimally invasive medical procedures for the diagnosis or treatment of vascular conditions. Hemostat (blood clotting) products consist of the D-Stat Dry hemostat, a topical thrombin-based pad with a bandage used to control surface bleeding, and the D-Stat Flowable. Vein products consist of the Vari-Lase endovenous laser. In December 2011, it acquired 5-year rights to sell reprocessing services for the ClosureFast catheter in the United States from Northeast Scientific, Inc. In June 2012, the Company acquired the radial artery access wrist positioning splint product assets of Accumed Systems, Inc.

Officers and directors

John L. Erb Independent Chairman of the Board
Age: 64
Bio & Compensation  - Reuters
Howard Root Chief Executive Officer, Director
Age: 52
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
James Hennen Chief Financial Officer, Senior Vice President - Finance, Corporate Secretary
Age: 40
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
William Rutstein Senior Vice President - Worldwide Sales
Age: 60
Bio & Compensation  - Reuters
Charmaine Sutton Senior Vice President - Operations
Age: 53
Bio & Compensation  - Reuters
Susan Christian Vice President - Sales Operations
Age: 44
Bio & Compensation  - Reuters
Carrie Powers Vice President - Marketing
Age: 38
Bio & Compensation  - Reuters
Brett Demchuk Vice President - Product Quality
Age: 49
Bio & Compensation  - Reuters
Jonathan M. Hammond Vice President - Manufacturing Engineering
Age: 45
Bio & Compensation  - Reuters
Phillip E Nalbone Vice President - Corporate Development
Age: 51
Bio & Compensation  - Reuters